News

Gene-editing breakthroughs are bringing curative therapies closer to reality. The challenge now is ensuring African health systems are ready to deliver them. At the…

Etavopivat is a new medicine under development for treating blood disorders like sickle cell disease and thalassaemia. Sickle cell disease and thalassaemia are…

Historically, sickle cell disease (SCD) has been overshadowed by progress in other hematologic disorders, but recent advances are reshaping its clinical and…

Sickle cell disease is a genetic red blood cell disorder, affecting millions of people globally. This Seminar provides a comprehensive update on the disease,…

A novel patient-reported outcome tool designed to capture home-managed sickle cell pain crises (SCPC) demonstrated strong content validity in adolescents and adults…

Sickle Cell 5K Road Race/WalkDateSat 5th September 2026Time9:00AM EDTLocationAtlanta, GeorgiaPriceFree - $55.00Races4 racesDistances5km

Cure Sickle Cell Walk & Family Fun Day in ActionIn this video recap of last year’s event, patient families and CHOP doctors share why they participate in the…

Adults with sickle cell disease (SCD) face a substantial risk of stroke, most often in their 30s and 40s, with lasting physical disability and cognitive impairment…

Across the 6MM countries, the Sickle Cell Disease market size was estimated at around USD 650 million in 2024 and is expected to experience steady growth over the…

In early February, Congress finally advanced, and the President signed into law, a funding package for federal programs for fiscal year (FY) 2026, which runs…